Home
Query results
Results for
DTNA
Expand for information on DTNA
DTNA
Description
dystrobrevin alpha
Aliases
D18S892E, DRP3, DTN, DTN-A, LVNC1
Gene Identifiers
mRNA Identifiers
RefSeq (mRNA)
NM_001128175.2; NM_001198938.2; NM_001198939.2; NM_001198940.2; NM_001198941.2; NM_001198942.1; NM_001198943.1; NM_001198944.1; NM_001198945.2; NM_001390.4; NM_001391.5; NM_001392.5; NM_032975.3; NM_032978.7; NM_032979.5; NM_032980.4; NM_032981.5; XM_005258221.5; XM_011525853.3; XM_017025575.2; XM_017025576.2; XM_017025577.2; XM_017025578.2; XM_017025579.2; XM_017025580.1; XM_017025581.2; XM_017025582.2; XM_017025584.2; XM_017025585.2; XM_017025586.2; XM_017025587.2; XM_017025588.2; XM_017025589.2; XM_017025590.2; XM_017025591.2; XM_017025593.2; XM_017025594.2; XM_017025595.1; XM_017025597.2; XM_017025598.2; XM_017025599.2; XM_017025600.2; XM_017025601.2; XM_017025602.2; XM_024451096.1; XM_024451097.1; XM_024451098.1
Protein Identifiers
RefSeq (protein)
NP_001121647.1; NP_001185867.1; NP_001185868.1; NP_001185869.1; NP_001185870.1; NP_001185871.1; NP_001185872.1; NP_001185873.1; NP_001185874.1; NP_001381.2; NP_001382.2; NP_001383.2; NP_116757.2; NP_116760.2; NP_116761.2; NP_116762.2; NP_116763.1; XP_005258278.1; XP_011524155.1; XP_016881064.1; XP_016881065.1; XP_016881066.1; XP_016881067.1; XP_016881068.1; XP_016881069.1; XP_016881070.1; XP_016881071.1; XP_016881073.1; XP_016881074.1; XP_016881075.1; XP_016881076.1; XP_016881077.1; XP_016881078.1; XP_016881079.1; XP_016881080.1; XP_016881082.1; XP_016881083.1; XP_016881084.1; XP_016881086.1; XP_016881087.1; XP_016881088.1; XP_016881089.1; XP_016881090.1; XP_016881091.1; XP_024306864.1; XP_024306865.1; XP_024306866.1
Uniprot ID
Ensembl protein ID
ENSP00000451516.2; ENSP00000470152.1; ENSP00000382072.5; ENSP00000473078.1; ENSP00000473119.1; ENSP00000269192.7; ENSP00000470247.1; ENSP00000452255.2; ENSP00000469121.1; ENSP00000405819.1; ENSP00000322519.5; ENSP00000283365.9; ENSP00000336682.4; ENSP00000472031.1; ENSP00000467720.1; ENSP00000471783.1; ENSP00000470716.1
Protein Architecture
SMART
Disease Mapping
Druggability
- Candidate cancer driver
- Damaged in 127/7921 TCGA samples
- Damaged in 28/1291 cell lines
- Fewer loss of function mutations
- Equal damaging SNVs/indels
- Fewer structural variants